PL378538A1 - Synteza (R) oraz (S)-aminokarnityny i ich pochodnych z kwasem D- oraz L-asparaginowym - Google Patents
Synteza (R) oraz (S)-aminokarnityny i ich pochodnych z kwasem D- oraz L-asparaginowymInfo
- Publication number
- PL378538A1 PL378538A1 PL378538A PL37853803A PL378538A1 PL 378538 A1 PL378538 A1 PL 378538A1 PL 378538 A PL378538 A PL 378538A PL 37853803 A PL37853803 A PL 37853803A PL 378538 A1 PL378538 A1 PL 378538A1
- Authority
- PL
- Poland
- Prior art keywords
- aminocarnitine
- derivatives
- aspartic acid
- synthesis
- acid
- Prior art date
Links
- DAWBGYHPBBDHMQ-ZCFIWIBFSA-N (3r)-3-amino-4-(trimethylazaniumyl)butanoate Chemical compound C[N+](C)(C)C[C@H](N)CC([O-])=O DAWBGYHPBBDHMQ-ZCFIWIBFSA-N 0.000 title abstract 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 title abstract 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 title 2
- DAWBGYHPBBDHMQ-LURJTMIESA-N (3s)-3-amino-4-(trimethylazaniumyl)butanoate Chemical compound C[N+](C)(C)C[C@@H](N)CC([O-])=O DAWBGYHPBBDHMQ-LURJTMIESA-N 0.000 title 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 title 1
- 229960005261 aspartic acid Drugs 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- XQKAYTBBWLDCBB-UHFFFAOYSA-N 3,4-diaminobutanoic acid Chemical compound NCC(N)CC(O)=O XQKAYTBBWLDCBB-UHFFFAOYSA-N 0.000 abstract 1
- NYSTXWQMQQTMBC-UHFFFAOYSA-N C[N+](C)(C)CC(CC([O-])=O)(N)O.P Chemical compound C[N+](C)(C)CC(CC([O-])=O)(N)O.P NYSTXWQMQQTMBC-UHFFFAOYSA-N 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/338,045 US20030153783A1 (en) | 1999-06-30 | 2003-01-08 | Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid |
| US10/372,627 US6822115B2 (en) | 1999-06-30 | 2003-02-25 | Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL378538A1 true PL378538A1 (pl) | 2006-05-02 |
Family
ID=32716886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL378538A PL378538A1 (pl) | 2003-01-08 | 2003-12-19 | Synteza (R) oraz (S)-aminokarnityny i ich pochodnych z kwasem D- oraz L-asparaginowym |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6822115B2 (enExample) |
| EP (1) | EP1581475B1 (enExample) |
| JP (1) | JP4642476B2 (enExample) |
| KR (1) | KR20050092398A (enExample) |
| CN (1) | CN1735588B (enExample) |
| AT (1) | ATE443039T1 (enExample) |
| AU (1) | AU2003295219B2 (enExample) |
| BR (1) | BR0317956A (enExample) |
| CA (1) | CA2512679A1 (enExample) |
| CY (1) | CY1109545T1 (enExample) |
| DE (1) | DE60329325D1 (enExample) |
| DK (1) | DK1581475T3 (enExample) |
| ES (1) | ES2333523T3 (enExample) |
| MX (1) | MXPA05007315A (enExample) |
| PL (1) | PL378538A1 (enExample) |
| PT (1) | PT1581475E (enExample) |
| SI (1) | SI1581475T1 (enExample) |
| WO (1) | WO2004063143A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1299266B1 (it) * | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
| ITRM20050090A1 (it) * | 2005-03-02 | 2006-09-03 | Sigma Tau Ind Farmaceutiche Riunite Spa | Derivati dell'acido ammino-butanoico inibitore della cpt. |
| US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
| CA2680366C (en) * | 2007-03-09 | 2016-06-21 | University Health Network | Inhibitors of carnitine palmitoyltransferase and treating cancer |
| WO2009015485A1 (en) * | 2007-08-01 | 2009-02-05 | University Health Network | Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| CN115974742A (zh) * | 2023-02-16 | 2023-04-18 | 中国水产科学研究院黄海水产研究所 | 温和条件下dmshb的制备与结构表征方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1136945B (it) * | 1981-03-18 | 1986-09-03 | Anic Spa | Processo per la preparazione di l-carnitina |
| IT1261489B (it) | 1993-07-29 | 1996-05-23 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione di r amminocarnitina e s amminocarnitina. |
| IT1299266B1 (it) * | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
| IT1306162B1 (it) * | 1999-06-30 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Sintesi di (r) e (s)-amminocarnitina e di suoi derivati a partire daacido d e l-aspartico. |
| US20030153783A1 (en) * | 1999-06-30 | 2003-08-14 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid |
-
2003
- 2003-02-25 US US10/372,627 patent/US6822115B2/en not_active Expired - Fee Related
- 2003-12-19 DK DK03786222.4T patent/DK1581475T3/da active
- 2003-12-19 AT AT03786222T patent/ATE443039T1/de active
- 2003-12-19 AU AU2003295219A patent/AU2003295219B2/en not_active Ceased
- 2003-12-19 JP JP2004566248A patent/JP4642476B2/ja not_active Expired - Fee Related
- 2003-12-19 WO PCT/IT2003/000846 patent/WO2004063143A1/en not_active Ceased
- 2003-12-19 CN CN2003801085435A patent/CN1735588B/zh not_active Expired - Fee Related
- 2003-12-19 DE DE60329325T patent/DE60329325D1/de not_active Expired - Lifetime
- 2003-12-19 KR KR1020057012832A patent/KR20050092398A/ko not_active Abandoned
- 2003-12-19 EP EP03786222A patent/EP1581475B1/en not_active Expired - Lifetime
- 2003-12-19 BR BRPI0317956-7A patent/BR0317956A/pt not_active IP Right Cessation
- 2003-12-19 CA CA002512679A patent/CA2512679A1/en not_active Abandoned
- 2003-12-19 ES ES03786222T patent/ES2333523T3/es not_active Expired - Lifetime
- 2003-12-19 MX MXPA05007315A patent/MXPA05007315A/es active IP Right Grant
- 2003-12-19 PL PL378538A patent/PL378538A1/pl not_active Application Discontinuation
- 2003-12-19 SI SI200331683T patent/SI1581475T1/sl unknown
- 2003-12-19 PT PT03786222T patent/PT1581475E/pt unknown
-
2009
- 2009-12-04 CY CY20091101274T patent/CY1109545T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2333523T3 (es) | 2010-02-23 |
| KR20050092398A (ko) | 2005-09-21 |
| CY1109545T1 (el) | 2014-08-13 |
| EP1581475B1 (en) | 2009-09-16 |
| HK1086254A1 (en) | 2006-09-15 |
| SI1581475T1 (sl) | 2009-12-31 |
| DK1581475T3 (da) | 2010-01-25 |
| PT1581475E (pt) | 2009-11-09 |
| CN1735588A (zh) | 2006-02-15 |
| MXPA05007315A (es) | 2005-09-30 |
| BR0317956A (pt) | 2006-06-13 |
| CN1735588B (zh) | 2010-05-26 |
| US20030153784A1 (en) | 2003-08-14 |
| JP4642476B2 (ja) | 2011-03-02 |
| AU2003295219A1 (en) | 2004-08-10 |
| AU2003295219B2 (en) | 2010-08-12 |
| WO2004063143A1 (en) | 2004-07-29 |
| CA2512679A1 (en) | 2004-07-29 |
| US6822115B2 (en) | 2004-11-23 |
| DE60329325D1 (de) | 2009-10-29 |
| EP1581475A1 (en) | 2005-10-05 |
| ATE443039T1 (de) | 2009-10-15 |
| JP2006513243A (ja) | 2006-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003097656A3 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
| WO2003042101A3 (en) | Ts-pq titano-silicate molecular sieves and methods for synthesis and use thereof | |
| BRPI0410685B8 (pt) | processos de purificação do 1,3-propanodiol e composição | |
| MXPA04000622A (es) | Pirazolilcarboxanilidas como funguicidas. | |
| WO2001004115A3 (en) | Novel process for synthesis of heteroaryl-substituted urea compounds | |
| MXPA04005099A (es) | Derivados de 5-sulfanil-4h-1,2,4-triazol y su uso como medicamento. | |
| GB0011203D0 (en) | Chemical compounds | |
| WO1998041513A3 (de) | Substituierte aminosalicylsäureamide mit fungizider wirkung und zwischenprodukte zu ihrer herstellung | |
| CY1109545T1 (el) | Συνθεση της (r) και (s)-αμινοκαρνιτινης και παραγωγων που προκυπτουν απο to d- και l- ασπαρτικο οξυ | |
| TR28332A (tr) | Arilasetik asit türevleri. | |
| SE0101038D0 (sv) | Novel compounds | |
| DE50310579D1 (de) | Furancarboxamide | |
| TR199802042T2 (xx) | Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�. | |
| NZ515108A (en) | Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments | |
| PL373468A1 (en) | Oxathiincarboxamides | |
| AU5844800A (en) | Synthesis of (r) and (s)-aminocarnitine and their derivatives starting from d- and l-aspartic acid | |
| WO2003080631A8 (en) | Plasma carboxypeptidase b inhibitors | |
| PL372933A1 (en) | Methylthiophene carboxanilides | |
| DE69926223D1 (de) | Verfahren zur herstellung von zwischenprodukten | |
| TR200001122T2 (tr) | Farmasötikler olarak bifenil türevleri. | |
| DE60019723D1 (de) | Eine methode zur herstellung von verbindungen der formel 1 und derivaten | |
| WO2002085877A3 (en) | Processes and intermediates for preparing benzyl substituted epoxides | |
| WO2002055454A3 (en) | Process and product | |
| DE60128367D1 (de) | Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren | |
| WO2003031381A3 (fr) | Synthese du (z) -3, 5, 4' trimethoxystilbene et son utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |